Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Enhanced Genomic Stability in Monomorphic Post-Transplant Lymphoproliferative Disorders Is Driven By Distinct Mechanisms Stratified By EBV Status

Lindsey Armitage, Sarah Gibson, Erika Moore, Chelsae Watters, Lee Wisner, David Li, Steven H. Swerdlow, Lisa M. Rimsza, Alanna Maguire

Blood (2023) 142 (Supplement 1): 6105.

https://doi.org/10.1182/blood-2023-182907

Published: 2023

Journal Articles

Pilot Trial of IFN-γ and Donor Lymphocyte Infusion to Treat Relapsed AML and MDS after Allogeneic Hematopoietic Stem Cell Transplantation

Sawa Ito, Elizabeth F Krakow, Kedwin Ventura, Amy Rodger, Emily Geramita, Erika Moore, Geoffrey R Hill, Warren D Shlomchik

Blood (2022) 140 (Supplement 1): 7678–7679.

https://doi.org/10.1182/blood-2022-157054

Published: 2022

Journal Articles

Safety and Efficacy of Venetoclax Combined with Rituximab, Ifosfamide, Carboplatin and Etoposide Chemoimmunotherapy (VICER) for Treatment of Relapsed Diffuse Large B Cell Lymphoma: Results from the Phase 1 Study

Paolo Caimi, MD, Deepa Jagadeesh, MDMPH, Kirsten Marie Boughan, DO, Robert M. Dean, MD, Brenda Cooper, MD, Brad Pohlman, MD, Molly M Gallogly, MDPhD, Sarah L. Ondrejka, DO, Erika Moore, MD, Kwadwo Asare Oduro, MDPhD, Eric D. Hsi, MD, Marcos de Lima, MD, Brian T. Hill, MD PhD

Blood (2018) 132 (Supplement 1): 397.

https://doi.org/10.1182/blood-2018-99-115587

Published: 2018

Journal Articles

Patterns of Care of Diffuse Large B Cell Lymphoma Patients 80 Years and Older: Worse Outcomes after Treatment without Increased Relapse

Madison Keenan, Kirsten Marie Boughan, DO, Brenda Cooper, MD, Molly M Gallogly, MDPhD, Stanton L. Gerson, MD, Hillard M Lazarus, MD, Ehsan Malek, MD, Leland Metheny, MD, Folashade Otegbeye, MBBChir, MPH, Benjamin K. Tomlinson, MD, Erika Moore, MD, Kwadwo Asare Oduro, MD PhD, Rose Beck, MD PhD, Howard Meyerson, MD, Marcos de Lima, MD, Paolo F Caimi, MD

Blood (2018) 132 (Supplement 1): 575.

https://doi.org/10.1182/blood-2018-99-117587

Published: 2018

Journal Articles

Effect of Histologic Grade on Clinical Outcomes of Follicular Lymphoma: Prolonged Progression Free Survival of Grade 3 Follicular Lymphoma in the Rituximab Era

Suchitra Sundaram, MBBS, Erika Moore, MD, Sabarish Ayyappan, MBBS, Fahrettin Covut, MD, Benjamin Tomlinson, MD, Richard Creger, PhD, Ehsan Malek, MD, Leland Metheny, MD, Brenda W. Cooper, MD, Hillard M Lazarus, MD, Marcos de Lima, MD, Paolo Caimi, MD

Blood (2017) 130 (Supplement 1): 2775.

https://doi.org/10.1182/blood.V130.Suppl_1.2775.2775

Published: 2017

Journal Articles

Clinicopathologic Characterization of Acute Myeloid Leukemia and Myelodysplastic Syndrome with Inv(3)(q21q26.2)/t(3;3)(q21;q26.2) Reveals That Complex Karyotype but Not Blast Percentage Is Associated with Poor Survival; A Bone Marrow Pathology Group Study

Heesun J. Rogers, MD, PhD, James W. Vardiman, MD, John Anastasi, MD, Gordana Raca, MD, PhD, Natasha M Savage, MD, Athena M Cherry, Ph.D., Daniel Arber, MD, Erika Moore, MD, Jennifer JD Morrissette, PhD, Adam Bagg, MD, Yen-Chun Liu, MD, PHD, Susan Mathew, PhD, Attilio Orazi, MD, Pei Lin, MD, Sa A. Wang, MD, Carlos E. Bueso-Ramos, MD, PhD, Kathryn Foucar, MD, Robert P Hasserjian, MD, Eric D. Hsi, MD

Blood (2012) 120 (21): 3847.

https://doi.org/10.1182/blood.V120.21.3847.3847

Published: 2012

NARROW

Enhanced Genomic Stability in Monomorphic Post-Transplant Lymphoproliferative Disorders Is Driven By Distinct Mechanisms Stratified By EBV Status

Pilot Trial of IFN-γ and Donor Lymphocyte Infusion to Treat Relapsed AML and MDS after Allogeneic Hematopoietic Stem Cell Transplantation

Safety and Efficacy of Venetoclax Combined with Rituximab, Ifosfamide, Carboplatin and Etoposide Chemoimmunotherapy (VICER) for Treatment of Relapsed Diffuse Large B Cell Lymphoma: Results from the Phase 1 Study

Patterns of Care of Diffuse Large B Cell Lymphoma Patients 80 Years and Older: Worse Outcomes after Treatment without Increased Relapse

Effect of Histologic Grade on Clinical Outcomes of Follicular Lymphoma: Prolonged Progression Free Survival of Grade 3 Follicular Lymphoma in the Rituximab Era

Clinicopathologic Characterization of Acute Myeloid Leukemia and Myelodysplastic Syndrome with Inv(3)(q21q26.2)/t(3;3)(q21;q26.2) Reveals That Complex Karyotype but Not Blast Percentage Is Associated with Poor Survival; A Bone Marrow Pathology Group Study

Email alerts

ASH Publications

American Society of Hematology

Enhanced Genomic Stability in Monomorphic Post-Transplant Lymphoproliferative Disorders Is Driven By Distinct Mechanisms Stratified By EBV Status

Pilot Trial of IFN-γ and Donor Lymphocyte Infusion to Treat Relapsed AML and MDS after Allogeneic Hematopoietic Stem Cell Transplantation

Safety and Efficacy of Venetoclax Combined with Rituximab, Ifosfamide, Carboplatin and Etoposide Chemoimmunotherapy (VICER) for Treatment of Relapsed Diffuse Large B Cell Lymphoma: Results from the Phase 1 Study

Patterns of Care of Diffuse Large B Cell Lymphoma Patients 80 Years and Older: Worse Outcomes after Treatment without Increased Relapse

Effect of Histologic Grade on Clinical Outcomes of Follicular Lymphoma: Prolonged Progression Free Survival of Grade 3 Follicular Lymphoma in the Rituximab Era

Clinicopathologic Characterization of Acute Myeloid Leukemia and Myelodysplastic Syndrome with Inv(3)(q21q26.2)/t(3;3)(q21;q26.2) Reveals That Complex Karyotype but Not Blast Percentage Is Associated with Poor Survival; A Bone Marrow Pathology Group Study

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only